Ispecimen INC Schedule 13G passive stakes

Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.

NASDAQ
OBF Investments, LLC and George H. Scholl have reported beneficial ownership of 4.4% of iSpecimen Inc.'s common stock, reflecting holdings after the company's one-for-twenty reverse stock split.